These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22135384)

  • 21. Muscarinic M1 Receptor Overstimulation Disrupts Working Memory Activity for Rules in Primate Prefrontal Cortex.
    Vijayraghavan S; Major AJ; Everling S
    Neuron; 2018 Jun; 98(6):1256-1268.e4. PubMed ID: 29887340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The processing of the selective M1 agonist CDD-0102-J by human hepatic drug metabolizing enzymes.
    Bachmann K; Telang U; Byers J; Hoss W
    Am J Ther; 2005; 12(4):300-5. PubMed ID: 16041192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infralimbic muscarinic M1 receptors modulate anxiety-like behaviour and spontaneous working memory in mice.
    Wall PM; Flinn J; Messier C
    Psychopharmacology (Berl); 2001 Apr; 155(1):58-68. PubMed ID: 11374337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates.
    Bontempi B; Whelan KT; Risbrough VB; Rao TS; Buccafusco JJ; Lloyd GK; Menzaghi F
    J Pharmacol Exp Ther; 2001 Oct; 299(1):297-306. PubMed ID: 11561092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
    Dunbar PG; Durant GJ; Fang Z; Abuh YF; el-Assadi AA; Ngur DO; Periyasamy S; Hoss WP; Messer WS
    J Med Chem; 1993 Apr; 36(7):842-7. PubMed ID: 8464038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-amnesic properties of (+/-)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats.
    Antonini V; Prezzavento O; Coradazzi M; Marrazzo A; Ronsisvalle S; Arena E; Leanza G
    J Neurochem; 2009 May; 109(3):744-54. PubMed ID: 19245662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation.
    Thomsen M; Conn PJ; Lindsley C; Wess J; Boon JY; Fulton BS; Fink-Jensen A; Caine SB
    J Pharmacol Exp Ther; 2010 Mar; 332(3):959-69. PubMed ID: 19996296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sabcomeline (SB-202026), a functionally selective M1 receptor partial agonist, reverses delay-induced deficits in the T-maze.
    Hatcher JP; Loudon JM; Hagan JJ; Clark MS
    Psychopharmacology (Berl); 1998 Aug; 138(3-4):275-82. PubMed ID: 9725749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
    Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
    Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist.
    Bartolomeo AC; Morris H; Buccafusco JJ; Kille N; Rosenzweig-Lipson S; Husbands MG; Sabb AL; Abou-Gharbia M; Moyer JA; Boast CA
    J Pharmacol Exp Ther; 2000 Feb; 292(2):584-96. PubMed ID: 10640295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
    Sams AG; Hentzer M; Mikkelsen GK; Larsen K; Bundgaard C; Plath N; Christoffersen CT; Bang-Andersen B
    J Med Chem; 2010 Sep; 53(17):6386-97. PubMed ID: 20684563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of hippocampal M1 muscarinic receptors impairs working memory performance of rats.
    Ohno M; Yamamoto T; Watanabe S
    Brain Res; 1994 Jul; 650(2):260-6. PubMed ID: 7953691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.
    McDonald MP; Willard LB; Wenk GL; Crawley JN
    J Neurosci; 1998 Jul; 18(13):5078-85. PubMed ID: 9634573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M
    Moran SP; Dickerson JW; Cho HP; Xiang Z; Maksymetz J; Remke DH; Lv X; Doyle CA; Rajan DH; Niswender CM; Engers DW; Lindsley CW; Rook JM; Conn PJ
    Neuropsychopharmacology; 2018 Jul; 43(8):1763-1771. PubMed ID: 29581537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice.
    Gautam D; Heard TS; Cui Y; Miller G; Bloodworth L; Wess J
    Mol Pharmacol; 2004 Aug; 66(2):260-7. PubMed ID: 15266016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
    Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
    Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels.
    Laplante F; Nakagawasai O; Srivastava LK; Quirion R
    Neuropsychopharmacology; 2005 Jun; 30(6):1076-87. PubMed ID: 15637638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
    Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
    Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
    Hamrouni AM; Gudka N; Broadley KJ
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.